SEI Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.2M Buy
963,827
+13,061
+1% +$219K 0.02% 785
2025
Q1
$14.6M Buy
950,766
+457,730
+93% +$7.04M 0.02% 818
2024
Q4
$10.9M Buy
493,036
+25,089
+5% +$553K 0.01% 950
2024
Q3
$8.43M Buy
467,947
+23,566
+5% +$425K 0.01% 1051
2024
Q2
$7.22M Sell
444,381
-12,941
-3% -$210K 0.01% 1060
2024
Q1
$6.45M Buy
457,322
+4,000
+0.9% +$56.4K 0.01% 1089
2023
Q4
$4.73M Buy
453,322
+95,489
+27% +$997K 0.01% 1211
2023
Q3
$3.65M Buy
+357,833
New +$3.65M 0.01% 1314
2022
Q3
Sell
-134,601
Closed -$1.01M 2731
2022
Q2
$1.01M Sell
134,601
-131,339
-49% -$987K ﹤0.01% 1829
2022
Q1
$2.5M Sell
265,940
-243
-0.1% -$2.28K 0.01% 1458
2021
Q4
$2.13M Buy
266,183
+92
+0% +$737 ﹤0.01% 1559
2021
Q3
$2.59M Hold
266,091
0.01% 1402
2021
Q2
$2.63M Buy
+266,091
New +$2.63M 0.01% 1382
2019
Q2
Sell
-20,774
Closed -$326K 2755
2019
Q1
$326K Sell
20,774
-157,669
-88% -$2.47M ﹤0.01% 2092
2018
Q4
$3.84M Buy
178,443
+49
+0% +$1.06K 0.01% 1023
2018
Q3
$3.84M Buy
178,394
+16,153
+10% +$348K 0.01% 997
2018
Q2
$3.95M Buy
162,241
+34,305
+27% +$834K 0.01% 1042
2018
Q1
$2.19M Sell
127,936
-546,069
-81% -$9.33M 0.01% 1176
2017
Q4
$12.8M Buy
674,005
+140,493
+26% +$2.66M 0.04% 507
2017
Q3
$9.39M Sell
533,512
-1,187,954
-69% -$20.9M 0.03% 620
2017
Q2
$57.2M Buy
1,721,466
+875,789
+104% +$29.1M 0.23% 84
2017
Q1
$27.1M Buy
845,677
+77,015
+10% +$2.47M 0.12% 189
2016
Q4
$27.9M Sell
768,662
-63,798
-8% -$2.31M 0.13% 161
2016
Q3
$38.3M Sell
832,460
-59,214
-7% -$2.72M 0.19% 115
2016
Q2
$44.8M Buy
891,674
+132,153
+17% +$6.64M 0.27% 77
2016
Q1
$40.6M Buy
759,521
+32,185
+4% +$1.72M 0.25% 96
2015
Q4
$47.7M Buy
727,336
+50,082
+7% +$3.29M 0.29% 69
2015
Q3
$38.2M Buy
677,254
+211,968
+46% +$12M 0.35% 58
2015
Q2
$27.5M Sell
465,286
-136,764
-23% -$8.08M 0.25% 104
2015
Q1
$37.5M Sell
602,050
-1,465
-0.2% -$91.2K 0.33% 71
2014
Q4
$34.7M Buy
+603,515
New +$34.7M 0.31% 79